Maternal-Fetal Physiologically Based Population Pharmacokinetics Model Development of Lopinavir/Ritonavir in HIV/HBV Co-infected Pregnant Women to Quantitatively Describe the Gestational PK Characteristics and Predict the Potential Disease-Drug-Drug Interaction (DDDI).

Saved in:
Bibliographic Details
Title: Maternal-Fetal Physiologically Based Population Pharmacokinetics Model Development of Lopinavir/Ritonavir in HIV/HBV Co-infected Pregnant Women to Quantitatively Describe the Gestational PK Characteristics and Predict the Potential Disease-Drug-Drug Interaction (DDDI).
Authors: Song L; Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China., Guo X; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China., Yang W; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China., Song J; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China., Liu D; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China. liudongyang@vip.sina.com.; Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, 100191, China. liudongyang@vip.sina.com.
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Jun; Vol. 64 (6), pp. 885-898. Date of Electronic Publication: 2025 May 05.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1926
DOI:10.1007/s40262-025-01493-5